Alyeska Investment Group, L.P. Vascular Biogenics Ltd. Transaction History
Alyeska Investment Group, L.P.
- $18 Billion
- Q3 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Vascular Biogenics Ltd. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 83,333 shares of VBLT stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83,333Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VBLT
# of Institutions
2Shares Held
416KCall Options Held
0Put Options Held
0About Vascular Biogenics Ltd.
- Ticker VBLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,348,896
- Description
- Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...